SlideShare a Scribd company logo
1 of 8
Download to read offline
31 July 2014
1QFY15 Results Update | Sector: Media
Jagran Prakashan
Shobhit Khare (Shobhit.Khare@MotilalOswal.com); +91 22 3982 5428
BSE SENSEX S&P CNX
CMP: INR119 TP: INR150 Buy25,895 7,721
Bloomberg JAGP IN
Equity Shares (m) 326.9
M.Cap. (INR b) / (USD b) 39.0/0.6
52-Week Range (INR) 140/78
1, 6, 12 Rel. Per (%) -10/8/-2
Financials & Valuation (INR Million)
Y/E MAR 2015E 2016E 2017E
Net Sales 18.5 20.6 22.5
EBITDA 4.4 5.1 5.6
A. Net Profit 2.3 2.9 3.4
A. EPS (INR) 7.5 9.3 10.9
A. EPSGr. (%) 16.5 24.2 17.2
BV/Sh (INR) 33.7 38.3 44.5
RoE (%) 23.1 25.8 26.3
RoCE (%) 16.3 18.5 19.5
D.payout(%) 62.6 50.4 43.0
Valuation
P/E (x) 15.9 12.8 10.9
P/BV (x) 3.5 3.1 2.7
EV/EBITDA(x) 8.8 7.4 6.4
Div. Yield (%) 3.4 3.4 3.4
 JAGP’s 1QFY15 EBITDA grew 5% YoY and 36% QoQ to INR1.07b (v/s est of
INR1.05b), supported by opex control even as revenue growth was muted.
 PAT (adjusted for exceptional items) declined 5% YoY but grew 81% QoQ to
INR551m. PAT was dragged down by additional ~INR50m quarterly depreciation
charge in line with accounting requirements as per the new company act.
However FY16 depreciation would likely decline YoY as the company follows
WDV.
 Ad revenue increased 7% YoY to INR3.09b (v/s est of INR3.16b), impacted by lack
of government advertising due to ‘model code of conduct’ and certain client
specific issues in the education category. Circulation revenue grew 11% YoY to
INR957m (v/s estimate of INR953m).
 Consolidated revenue grew 7% YoY to INR4.4b (v/s estimate of INR4.5b).
 Consolidated EBITDA margin declined 40bp YoY to 24.3% led by increase in RM
costs (up 270bp YoY). RM cost increased ~15% YoY led by ~12% newsprint price
increase. We expect newsprint prices to correct going forward.
 Other exp. declined 4% YoY and 16% QoQ on overall opex control, lower direct
expenses in outdoor/event/digital and lower write-off/provision for bad debts
Valuation and view
 Jagran’s 1QFY15 performance was broadly in line. While growth is likely to
remain muted in 1HFY15, we expect strong earnings rebound led by acceleration
in ad growth and decline in newsprint prices vs current levels.
 We are downgrading FY15 PAT by ~5% to factor-in ~1% EBITDA downgrade and
higher depreciation rate. Our FY16 PAT is largely unchanged. We expect
proforma EPS CAGR of 20% over FY14-16E driven by 11% ad revenue CAGR and
EBITDA margin expansion of ~210 bps.
 The stock trades at P/E of 15.9x FY15E and 12.8x FY16E. Maintain Buy with a
price target of INR150 based on 16x FY16 EPS.
Investors are advised to refer through disclosures made at the end of the Research Report.
31 July 2014 2
Jagran Prakashan
Standalone ad/circulation revenue (including Nai Duniya from 4QFY13)
Source: Company, MOSL
Standalone YoY ad growth (%)
Source: Company, MOSL
Standalone EBITDA (incl Nai Duniya from 4QFY13)
Source: Company, MOSL
RM/Sales (Consolidated from 1QFY14)
Source: Company, MOSL
1,898
1,935
1,945
1,887
2,043
2,119
2,235
2,103
2,207
2,196
2,393
2,276
2,685
2,630
3,000
2,647
2,880
553
548
570
559
582
612
623
628
641
666
699
761
795
826
861
860
896
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
Advertising revenue (INR m) Circulation revenue (INR m)
18
13
31
20
8 10
15
11
8
4
7
0
12 11
15 16
7
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
705
832
653
633
902
908
897
714
820
791
851
659
788
782
911
540
1013
911
1090
797
1059
30
34
29 27
33 33 31
25 27 26 26
21
25 24 26
16
26
24 25
20
26
1QFY10
2QFY10
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
EBITDA (INR m) EBITDA margin (%)
701
684
674
678
756
801
863
911
989
1,075
1,135
1,082
1,135
1,109
1,179
1,240
1,416
1,473
1,627
1,571
1,627
30 28 30 29 28 29 30 32 32 35 35 35 36 34 34 36 34 36 36 37 37
1QFY10
2QFY10
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
RM cost (INR m) RM cost (% of rev)
31 July 2014 3
Jagran Prakashan
Consolidated quarterly performance
1QFY14 4QFY14 1QFY15 YoY (%) QoQ (%) 1QFY15E v/s est (%)
Advertising revenue 2,898 2,917 3,089 6.6 5.9 3,158 -2.2
Circulation revenue 863 887 957 10.8 7.8 953 0.3
Others 370 403 357 -3.3 -11.4 384 -7.0
Revenue 4,131 4,207 4,403 6.6 4.6 4,496 -2.1
Total operating cost 3,111 3,418 3,333 7.1 -2.5 3,446 -3.3
EBITDA 1,019 790 1,070 5.0 35.6 1,051 1.9
EBITDA margin (%) 24.7 18.8 24.3 -37bps 554bps 23.4 94bps
Depreciation 181 220 238 31.6 8.1 222 7.1
EBIT 838 569 832 -0.7 46.2 829 0.5
Interest 71 101 84 17.5 -17.1 85 -1.5
Other Income incl sale of property -12 458 69 -687.5 -84.9 100 -30.8
Exceptional items (title amortization) 101
PBT 755 826 818 8.3 -1.0 844 -3.0
Tax 177 274 267 50.4 NA 261 NA
Tax rate (%) 23 33 33 915bps -55bps 31 165bps
Reported PAT 578 552 551 -4.7 -0.2 582 -5.4
Exceptional/prior period items 248 NA NA
Adjusted PAT 578 304 551 -4.7 81.2 582 -5.4
Operating expenses (INR m)
Raw material 1,416 1,571 1,627 14.9 3.6 1,626 0.1
Employee 600 585 648 8.0 10.7 648 0.0
Others 1,095 1,262 1,058 -3.5 -16.2 1,172 -9.8
Total 3,111 3,418 3,333 7.1 -2.5 3,446 -3.3
Opex (% of revenue)
Raw material 34.3 37.3 37.0 268bps -37bps
Employee 14.5 13.9 14.7 19bps 81bps
Others 26.5 30.0 24.0 -250bps -598bps
Source: Company, MOSL
Summary of estimate change (INR b)
FY15E FY16E
Revenue
Old 18.72 20.71
New 18.52 20.61
Change (%) -1.1 -0.5
EBITDA
Old 4.43 5.10
New 4.38 5.06
Change (%) -1.0 -0.8
EBITDA margin (%)
Old 23.7 24.6
New 23.7 24.5
Change (bp) 1 -8
Adj. PAT
Old 2.45 2.93
New 2.33 2.89
Change (%) -5.0 -1.3
Adj. EPS (INR)
Old 7.9 9.4
New 7.5 9.3
Change (%) -5.0 -1.3
Source: Company, MOSL
31 July 2014 4
Jagran Prakashan
Key assumptions & other data
FY10 FY11 FY12 FY13 FY14 FY15E FY16E FY17E
Group ad revenue (INR b) 6.4 8.5 9.4 10.5 11.9 13.0 14.5 15.8
YoY (%) 16 34 10 12 13 9 12 9
-Standalone (exc. Nai Duniya) 6.4 7.7 8.5 8.9 10.0 11.0 12.4 13.5
YoY (%) 16 20 11 4 13 10 12 9
-Mid-Day + Inquilab 0.8 0.9 0.9 0.9 0.9 0.9 1.0 1.0
YoY (%) 4 2 -2 5 3 3 3
-Nai Duniya 0.8 0.9 1.0 1.2 1.3
YoY (%) 13 16 11 13 13
Group circulation revenue (INR b) 2.1 2.4 2.7 3.2 3.6 4.0 4.5 5.0
YoY (%) 9 12 11 20 12 10 13 11
-Standalone (exc. Nai Duniya) 2.1 2.2 2.4 2.7 3.1 3.4 3.9 4.3
YoY (%) 10 4 10 11 13 11 13 12
-Mid-Day + Inquilab 0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.3
YoY (%) 4 28 9 5 9 9 8
-Nai Duniya 0.3 0.3 0.3 0.3 0.3
YoY (%) 25 10 10 10 0
Dainik Jagran av circulation/day (m) 2.7 3.0 3.2 3.5 3.6 3.9 4.1 4.3
YoY (%) -2 11 8 7 4 7 7 5
Newsprint price (USD/ton) 505 573 652 610 586 592 597 603
YoY (%) -20 13 14 -6 -4 1 1 1
RM cost/Revenue (%) 29 29 34 32 32 32 32 32
Revenue mix (%)
Ad revenue 68 70 69 69 70 70 70 70
Circulation revenue 23 20 20 21 21 21 22 22
Other 10 11 11 10 9 9 8 8
Source: Company, MOSL
31 July 2014 5
Jagran Prakashan
Jagran Prakashan: an investment profile
Company description
Jagran Prakashan Ltd (JPL) is a leading media and
communications group with its main interests across
Newspaper, Outdoor, Internet, Magazine, Event
Management and Short Code Sevice media, spanning
across 11 states. JPL is a leading newspaper publisher.
It's flagship brand Dainik Jagran has been the largest
read and circulated newspaper in India. JPL has 3
newspaper titles - Dainik Jagran, I next and City Plus.
Dainik Jagran is a Hindi newspaper printed out of 31
locations across 11 states, I next is a bilingual compact
morning newspaper targeted at 18-35 yrs, SEC AB1 in
key metros, while City Plus is a weekly English tabloid
circulated in Gurgaon, Faridabad, Ghaziabad, Noida and
Delhi.
Key investment argument
 Strong presence in tier II/III towns across the Hindi
speaking belt
 Footprint expansion led by Mid-Day and 'Nai
Duniya' acquisitions
 High dividend pay-out
Key investment risks
 High exposure to the UP print market
 Increased competition in UP and Bihar markets
Recent developments
 Jagran’s board approved a final dividend of
INR3/sh.
Valuation and view
 We are downgrading FY15 PAT by ~5% to factor-in
~1% EBITDA downgrade and higher depreciation
rate. Our FY16 PAT is largely unchanged. We
expect proforma EPS CAGR of 20% over FY14-16E
driven by 11% ad revenue CAGR and EBITDA
margin expansion of ~210 bps.
 The stock trades at P/E of 15.9x FY15E and 12.8x
FY16E. Maintain Buy with a price target of INR150
based on 16x FY16 EPS.
Comparative valuations
Jagran HT Media DB Corp
P/E (x) FY15E 15.9 12.7 17.0
FY16E 12.8 11.5 14.3
EV/EBITDA (x) FY15E 8.8 5.0 9.6
FY16E 7.4 3.7 8.1
Div. Yield (%) FY15E 3.4 0.3 2.6
FY16E 3.4 0.4 3.1
P/BV (x) FY15E 3.5 1.2 4.6
FY16E 3.1 1.0 4.0
EPS: MOSL forecast v/s consensus (INR)
MOSL Consensus Variation
Forecast Forecast (%)
FY15 7.5 8.3 -9.2
FY16 9.3 9.7 -4.0
Target price and recommendation
Current Target Upside Reco.
Price (INR) Price (INR) (%)
119 150 26 Buy
Shareholding pattern (%)
Mar-14 Dec-13 Mar-13
Promoter 62.6 61.6 61.6
DII 9.1 5.3 13.0
FII 14.0 7.3 12.6
Others 14.4 25.7 12.8
Notes: FII includes depository receipts
Stock performance (1-year)
31 July 2014 6
Jagran Prakashan
Financials and valuation
31 July 2014 7
Jagran Prakashan
N O T E S
31 July 2014 8
Jagran Prakashan
Disclosures
This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This
report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to
invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been
furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into
account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable
for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and
investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur.
MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business
relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection
processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that
the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may
interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the
profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from
maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an
officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading
strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with
the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and
its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in
any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its
affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to
hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The
information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt’s interpretation of the
data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not
intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt
and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its
affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of
its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of
merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations.
Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its
contents.
MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of
Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.
Disclosure of Interest Statement JAGRAN PRAKASHAN LTD
 Analyst ownership of the stock No
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or
will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible
for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to
law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions.
For U.K.
This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to
which this document relates is only available to investment professionals and will be engaged in only with such persons.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States.
In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state
laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein
are not available to or intended for U.S. persons.
This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional
investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major
institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as
amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has
entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be
executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer,
MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research
analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors
Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore
to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time.
In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited:
Anosh Koppikar Kadambari Balachandran
Email:anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com
Contact(+65)68189232 Contact: (+65) 68189233 / 65249115
Office Address:21 (Suite 31),16 Collyer Quay,Singapore 04931
Motilal Oswal Securities Ltd
Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025
Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com

More Related Content

What's hot

Gcpl 1 qfy2015ru_310714
Gcpl 1 qfy2015ru_310714Gcpl 1 qfy2015ru_310714
Gcpl 1 qfy2015ru_310714Bhavnesh Mutha
 
RU-ALL-Q3FY12-RKG
RU-ALL-Q3FY12-RKGRU-ALL-Q3FY12-RKG
RU-ALL-Q3FY12-RKGAditya Jha
 
2006 06-28 Q3 2005/2006 Results
2006 06-28 Q3 2005/2006 Results2006 06-28 Q3 2005/2006 Results
2006 06-28 Q3 2005/2006 ResultsKappAhl
 
TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017Share Rora
 
Color Life (1778.HK)
Color Life (1778.HK)Color Life (1778.HK)
Color Life (1778.HK)Evie Song
 
Venus Remedies Research Report Update
Venus Remedies Research Report UpdateVenus Remedies Research Report Update
Venus Remedies Research Report UpdateValueinvest
 
Indoco ru2 qfy2011-251010
Indoco ru2 qfy2011-251010Indoco ru2 qfy2011-251010
Indoco ru2 qfy2011-251010Angel Broking
 
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, marginsIndiaNotes.com
 
See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...
See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...
See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...NARNOLIA SECURITIES LIMITED
 
Q3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideQ3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideIndiaNotes.com
 
Sun Pharma: Compelling valuation post stake sale of Daiichi; Buy
Sun Pharma: Compelling valuation post stake sale of Daiichi; BuySun Pharma: Compelling valuation post stake sale of Daiichi; Buy
Sun Pharma: Compelling valuation post stake sale of Daiichi; BuyIndiaNotes.com
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldIndiaNotes.com
 
Colgate ru2 qfy2011-281010
Colgate  ru2 qfy2011-281010Colgate  ru2 qfy2011-281010
Colgate ru2 qfy2011-281010Angel Broking
 
Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015IndiaNotes.com
 
Wolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year ResultsWolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year ResultsWolters Kluwer
 
SKF First-quarter 2011 result slide show
SKF First-quarter 2011 result slide show SKF First-quarter 2011 result slide show
SKF First-quarter 2011 result slide show SKF
 
Fag bearing ru3 qcy2010-221010
Fag bearing ru3 qcy2010-221010Fag bearing ru3 qcy2010-221010
Fag bearing ru3 qcy2010-221010Angel Broking
 
SIKA IR Deck - January 2015
SIKA IR Deck - January 2015SIKA IR Deck - January 2015
SIKA IR Deck - January 2015SYGroup
 

What's hot (20)

Gcpl 1 qfy2015ru_310714
Gcpl 1 qfy2015ru_310714Gcpl 1 qfy2015ru_310714
Gcpl 1 qfy2015ru_310714
 
RU-ALL-Q3FY12-RKG
RU-ALL-Q3FY12-RKGRU-ALL-Q3FY12-RKG
RU-ALL-Q3FY12-RKG
 
2006 06-28 Q3 2005/2006 Results
2006 06-28 Q3 2005/2006 Results2006 06-28 Q3 2005/2006 Results
2006 06-28 Q3 2005/2006 Results
 
TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017
 
Color Life (1778.HK)
Color Life (1778.HK)Color Life (1778.HK)
Color Life (1778.HK)
 
Venus Remedies Research Report Update
Venus Remedies Research Report UpdateVenus Remedies Research Report Update
Venus Remedies Research Report Update
 
Indoco ru2 qfy2011-251010
Indoco ru2 qfy2011-251010Indoco ru2 qfy2011-251010
Indoco ru2 qfy2011-251010
 
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 
AAC & Sunny Final
AAC & Sunny FinalAAC & Sunny Final
AAC & Sunny Final
 
See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...
See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...
See the Chart of Indian IIP Trend in Narnolia Securities Limited Market Diary...
 
Q3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideQ3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upside
 
Piaggio Group - First Quarter 2012 Financial Results
Piaggio Group - First Quarter 2012 Financial ResultsPiaggio Group - First Quarter 2012 Financial Results
Piaggio Group - First Quarter 2012 Financial Results
 
Sun Pharma: Compelling valuation post stake sale of Daiichi; Buy
Sun Pharma: Compelling valuation post stake sale of Daiichi; BuySun Pharma: Compelling valuation post stake sale of Daiichi; Buy
Sun Pharma: Compelling valuation post stake sale of Daiichi; Buy
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
 
Colgate ru2 qfy2011-281010
Colgate  ru2 qfy2011-281010Colgate  ru2 qfy2011-281010
Colgate ru2 qfy2011-281010
 
Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015
 
Wolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year ResultsWolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year Results
 
SKF First-quarter 2011 result slide show
SKF First-quarter 2011 result slide show SKF First-quarter 2011 result slide show
SKF First-quarter 2011 result slide show
 
Fag bearing ru3 qcy2010-221010
Fag bearing ru3 qcy2010-221010Fag bearing ru3 qcy2010-221010
Fag bearing ru3 qcy2010-221010
 
SIKA IR Deck - January 2015
SIKA IR Deck - January 2015SIKA IR Deck - January 2015
SIKA IR Deck - January 2015
 

Similar to Jagran Prakashan Q1FY15: Buy

Hindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, BuyHindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, BuyIndiaNotes.com
 
Jaypee Infratech: Lowest quarterly PAT in four years - Jaypee
Jaypee Infratech: Lowest quarterly PAT in four years - JaypeeJaypee Infratech: Lowest quarterly PAT in four years - Jaypee
Jaypee Infratech: Lowest quarterly PAT in four years - JaypeeIndiaNotes.com
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; HoldIndiaNotes.com
 
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal OswalSun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal OswalIndiaNotes.com
 
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 LIC Housing Finance Q1FY15 performance in line with estimates; buy LIC Housing Finance Q1FY15 performance in line with estimates; buy
LIC Housing Finance Q1FY15 performance in line with estimates; buyIndiaNotes.com
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQIndiaNotes.com
 
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...IndiaNotes.com
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutralIndiaNotes.com
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalIndiaNotes.com
 
Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014IndiaNotes.com
 
Mastek 1QFY18
Mastek 1QFY18Mastek 1QFY18
Mastek 1QFY18Mohit Jn
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18Mohit Jn
 
DB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investmentDB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investmentIndiaNotes.com
 
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'IndiaNotes.com
 
Q1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability levelQ1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability levelIndiaNotes.com
 
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 TVS Motor Q1FY15: Business outlook strong; New launch impacts margins TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
TVS Motor Q1FY15: Business outlook strong; New launch impacts marginsIndiaNotes.com
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIndiaNotes.com
 
Bharti Airtel 1QFY15 revenue above estimates; buy
 Bharti Airtel 1QFY15 revenue above estimates; buy Bharti Airtel 1QFY15 revenue above estimates; buy
Bharti Airtel 1QFY15 revenue above estimates; buyIndiaNotes.com
 
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyBajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyIndiaNotes.com
 

Similar to Jagran Prakashan Q1FY15: Buy (20)

Hindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, BuyHindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
 
Jaypee Infratech: Lowest quarterly PAT in four years - Jaypee
Jaypee Infratech: Lowest quarterly PAT in four years - JaypeeJaypee Infratech: Lowest quarterly PAT in four years - Jaypee
Jaypee Infratech: Lowest quarterly PAT in four years - Jaypee
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal OswalSun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
 
Bata india
Bata indiaBata india
Bata india
 
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 LIC Housing Finance Q1FY15 performance in line with estimates; buy LIC Housing Finance Q1FY15 performance in line with estimates; buy
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
 
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutral
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal Oswal
 
Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014
 
Mastek 1QFY18
Mastek 1QFY18Mastek 1QFY18
Mastek 1QFY18
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18
 
DB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investmentDB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investment
 
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
 
Q1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability levelQ1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability level
 
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 TVS Motor Q1FY15: Business outlook strong; New launch impacts margins TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buy
 
Bharti Airtel 1QFY15 revenue above estimates; buy
 Bharti Airtel 1QFY15 revenue above estimates; buy Bharti Airtel 1QFY15 revenue above estimates; buy
Bharti Airtel 1QFY15 revenue above estimates; buy
 
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyBajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 

Recently uploaded

Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designsegoetzinger
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyTyöeläkeyhtiö Elo
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证rjrjkk
 
Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]Commonwealth
 
Vp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsAppVp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsAppmiss dipika
 
Classical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithClassical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithAdamYassin2
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Roomdivyansh0kumar0
 
Bladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawlmakika9823
 
SBP-Market-Operations and market managment
SBP-Market-Operations and market managmentSBP-Market-Operations and market managment
SBP-Market-Operations and market managmentfactical
 
Stock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdfStock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdfMichael Silva
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...Suhani Kapoor
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
fca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdffca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdfHenry Tapper
 
The Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh KumarThe Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh KumarHarsh Kumar
 
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxOAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxhiddenlevers
 

Recently uploaded (20)

Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designs
 
Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
 
🔝+919953056974 🔝young Delhi Escort service Pusa Road
🔝+919953056974 🔝young Delhi Escort service Pusa Road🔝+919953056974 🔝young Delhi Escort service Pusa Road
🔝+919953056974 🔝young Delhi Escort service Pusa Road
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
 
Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]
 
Vp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsAppVp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsApp
 
Classical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithClassical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam Smith
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
 
Bladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results Presentation
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
 
SBP-Market-Operations and market managment
SBP-Market-Operations and market managmentSBP-Market-Operations and market managment
SBP-Market-Operations and market managment
 
Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024
 
Stock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdfStock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdf
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
fca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdffca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdf
 
The Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh KumarThe Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh Kumar
 
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxOAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
 

Jagran Prakashan Q1FY15: Buy

  • 1. 31 July 2014 1QFY15 Results Update | Sector: Media Jagran Prakashan Shobhit Khare (Shobhit.Khare@MotilalOswal.com); +91 22 3982 5428 BSE SENSEX S&P CNX CMP: INR119 TP: INR150 Buy25,895 7,721 Bloomberg JAGP IN Equity Shares (m) 326.9 M.Cap. (INR b) / (USD b) 39.0/0.6 52-Week Range (INR) 140/78 1, 6, 12 Rel. Per (%) -10/8/-2 Financials & Valuation (INR Million) Y/E MAR 2015E 2016E 2017E Net Sales 18.5 20.6 22.5 EBITDA 4.4 5.1 5.6 A. Net Profit 2.3 2.9 3.4 A. EPS (INR) 7.5 9.3 10.9 A. EPSGr. (%) 16.5 24.2 17.2 BV/Sh (INR) 33.7 38.3 44.5 RoE (%) 23.1 25.8 26.3 RoCE (%) 16.3 18.5 19.5 D.payout(%) 62.6 50.4 43.0 Valuation P/E (x) 15.9 12.8 10.9 P/BV (x) 3.5 3.1 2.7 EV/EBITDA(x) 8.8 7.4 6.4 Div. Yield (%) 3.4 3.4 3.4  JAGP’s 1QFY15 EBITDA grew 5% YoY and 36% QoQ to INR1.07b (v/s est of INR1.05b), supported by opex control even as revenue growth was muted.  PAT (adjusted for exceptional items) declined 5% YoY but grew 81% QoQ to INR551m. PAT was dragged down by additional ~INR50m quarterly depreciation charge in line with accounting requirements as per the new company act. However FY16 depreciation would likely decline YoY as the company follows WDV.  Ad revenue increased 7% YoY to INR3.09b (v/s est of INR3.16b), impacted by lack of government advertising due to ‘model code of conduct’ and certain client specific issues in the education category. Circulation revenue grew 11% YoY to INR957m (v/s estimate of INR953m).  Consolidated revenue grew 7% YoY to INR4.4b (v/s estimate of INR4.5b).  Consolidated EBITDA margin declined 40bp YoY to 24.3% led by increase in RM costs (up 270bp YoY). RM cost increased ~15% YoY led by ~12% newsprint price increase. We expect newsprint prices to correct going forward.  Other exp. declined 4% YoY and 16% QoQ on overall opex control, lower direct expenses in outdoor/event/digital and lower write-off/provision for bad debts Valuation and view  Jagran’s 1QFY15 performance was broadly in line. While growth is likely to remain muted in 1HFY15, we expect strong earnings rebound led by acceleration in ad growth and decline in newsprint prices vs current levels.  We are downgrading FY15 PAT by ~5% to factor-in ~1% EBITDA downgrade and higher depreciation rate. Our FY16 PAT is largely unchanged. We expect proforma EPS CAGR of 20% over FY14-16E driven by 11% ad revenue CAGR and EBITDA margin expansion of ~210 bps.  The stock trades at P/E of 15.9x FY15E and 12.8x FY16E. Maintain Buy with a price target of INR150 based on 16x FY16 EPS. Investors are advised to refer through disclosures made at the end of the Research Report.
  • 2. 31 July 2014 2 Jagran Prakashan Standalone ad/circulation revenue (including Nai Duniya from 4QFY13) Source: Company, MOSL Standalone YoY ad growth (%) Source: Company, MOSL Standalone EBITDA (incl Nai Duniya from 4QFY13) Source: Company, MOSL RM/Sales (Consolidated from 1QFY14) Source: Company, MOSL 1,898 1,935 1,945 1,887 2,043 2,119 2,235 2,103 2,207 2,196 2,393 2,276 2,685 2,630 3,000 2,647 2,880 553 548 570 559 582 612 623 628 641 666 699 761 795 826 861 860 896 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 Advertising revenue (INR m) Circulation revenue (INR m) 18 13 31 20 8 10 15 11 8 4 7 0 12 11 15 16 7 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 705 832 653 633 902 908 897 714 820 791 851 659 788 782 911 540 1013 911 1090 797 1059 30 34 29 27 33 33 31 25 27 26 26 21 25 24 26 16 26 24 25 20 26 1QFY10 2QFY10 3QFY10 4QFY10 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 EBITDA (INR m) EBITDA margin (%) 701 684 674 678 756 801 863 911 989 1,075 1,135 1,082 1,135 1,109 1,179 1,240 1,416 1,473 1,627 1,571 1,627 30 28 30 29 28 29 30 32 32 35 35 35 36 34 34 36 34 36 36 37 37 1QFY10 2QFY10 3QFY10 4QFY10 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 RM cost (INR m) RM cost (% of rev)
  • 3. 31 July 2014 3 Jagran Prakashan Consolidated quarterly performance 1QFY14 4QFY14 1QFY15 YoY (%) QoQ (%) 1QFY15E v/s est (%) Advertising revenue 2,898 2,917 3,089 6.6 5.9 3,158 -2.2 Circulation revenue 863 887 957 10.8 7.8 953 0.3 Others 370 403 357 -3.3 -11.4 384 -7.0 Revenue 4,131 4,207 4,403 6.6 4.6 4,496 -2.1 Total operating cost 3,111 3,418 3,333 7.1 -2.5 3,446 -3.3 EBITDA 1,019 790 1,070 5.0 35.6 1,051 1.9 EBITDA margin (%) 24.7 18.8 24.3 -37bps 554bps 23.4 94bps Depreciation 181 220 238 31.6 8.1 222 7.1 EBIT 838 569 832 -0.7 46.2 829 0.5 Interest 71 101 84 17.5 -17.1 85 -1.5 Other Income incl sale of property -12 458 69 -687.5 -84.9 100 -30.8 Exceptional items (title amortization) 101 PBT 755 826 818 8.3 -1.0 844 -3.0 Tax 177 274 267 50.4 NA 261 NA Tax rate (%) 23 33 33 915bps -55bps 31 165bps Reported PAT 578 552 551 -4.7 -0.2 582 -5.4 Exceptional/prior period items 248 NA NA Adjusted PAT 578 304 551 -4.7 81.2 582 -5.4 Operating expenses (INR m) Raw material 1,416 1,571 1,627 14.9 3.6 1,626 0.1 Employee 600 585 648 8.0 10.7 648 0.0 Others 1,095 1,262 1,058 -3.5 -16.2 1,172 -9.8 Total 3,111 3,418 3,333 7.1 -2.5 3,446 -3.3 Opex (% of revenue) Raw material 34.3 37.3 37.0 268bps -37bps Employee 14.5 13.9 14.7 19bps 81bps Others 26.5 30.0 24.0 -250bps -598bps Source: Company, MOSL Summary of estimate change (INR b) FY15E FY16E Revenue Old 18.72 20.71 New 18.52 20.61 Change (%) -1.1 -0.5 EBITDA Old 4.43 5.10 New 4.38 5.06 Change (%) -1.0 -0.8 EBITDA margin (%) Old 23.7 24.6 New 23.7 24.5 Change (bp) 1 -8 Adj. PAT Old 2.45 2.93 New 2.33 2.89 Change (%) -5.0 -1.3 Adj. EPS (INR) Old 7.9 9.4 New 7.5 9.3 Change (%) -5.0 -1.3 Source: Company, MOSL
  • 4. 31 July 2014 4 Jagran Prakashan Key assumptions & other data FY10 FY11 FY12 FY13 FY14 FY15E FY16E FY17E Group ad revenue (INR b) 6.4 8.5 9.4 10.5 11.9 13.0 14.5 15.8 YoY (%) 16 34 10 12 13 9 12 9 -Standalone (exc. Nai Duniya) 6.4 7.7 8.5 8.9 10.0 11.0 12.4 13.5 YoY (%) 16 20 11 4 13 10 12 9 -Mid-Day + Inquilab 0.8 0.9 0.9 0.9 0.9 0.9 1.0 1.0 YoY (%) 4 2 -2 5 3 3 3 -Nai Duniya 0.8 0.9 1.0 1.2 1.3 YoY (%) 13 16 11 13 13 Group circulation revenue (INR b) 2.1 2.4 2.7 3.2 3.6 4.0 4.5 5.0 YoY (%) 9 12 11 20 12 10 13 11 -Standalone (exc. Nai Duniya) 2.1 2.2 2.4 2.7 3.1 3.4 3.9 4.3 YoY (%) 10 4 10 11 13 11 13 12 -Mid-Day + Inquilab 0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.3 YoY (%) 4 28 9 5 9 9 8 -Nai Duniya 0.3 0.3 0.3 0.3 0.3 YoY (%) 25 10 10 10 0 Dainik Jagran av circulation/day (m) 2.7 3.0 3.2 3.5 3.6 3.9 4.1 4.3 YoY (%) -2 11 8 7 4 7 7 5 Newsprint price (USD/ton) 505 573 652 610 586 592 597 603 YoY (%) -20 13 14 -6 -4 1 1 1 RM cost/Revenue (%) 29 29 34 32 32 32 32 32 Revenue mix (%) Ad revenue 68 70 69 69 70 70 70 70 Circulation revenue 23 20 20 21 21 21 22 22 Other 10 11 11 10 9 9 8 8 Source: Company, MOSL
  • 5. 31 July 2014 5 Jagran Prakashan Jagran Prakashan: an investment profile Company description Jagran Prakashan Ltd (JPL) is a leading media and communications group with its main interests across Newspaper, Outdoor, Internet, Magazine, Event Management and Short Code Sevice media, spanning across 11 states. JPL is a leading newspaper publisher. It's flagship brand Dainik Jagran has been the largest read and circulated newspaper in India. JPL has 3 newspaper titles - Dainik Jagran, I next and City Plus. Dainik Jagran is a Hindi newspaper printed out of 31 locations across 11 states, I next is a bilingual compact morning newspaper targeted at 18-35 yrs, SEC AB1 in key metros, while City Plus is a weekly English tabloid circulated in Gurgaon, Faridabad, Ghaziabad, Noida and Delhi. Key investment argument  Strong presence in tier II/III towns across the Hindi speaking belt  Footprint expansion led by Mid-Day and 'Nai Duniya' acquisitions  High dividend pay-out Key investment risks  High exposure to the UP print market  Increased competition in UP and Bihar markets Recent developments  Jagran’s board approved a final dividend of INR3/sh. Valuation and view  We are downgrading FY15 PAT by ~5% to factor-in ~1% EBITDA downgrade and higher depreciation rate. Our FY16 PAT is largely unchanged. We expect proforma EPS CAGR of 20% over FY14-16E driven by 11% ad revenue CAGR and EBITDA margin expansion of ~210 bps.  The stock trades at P/E of 15.9x FY15E and 12.8x FY16E. Maintain Buy with a price target of INR150 based on 16x FY16 EPS. Comparative valuations Jagran HT Media DB Corp P/E (x) FY15E 15.9 12.7 17.0 FY16E 12.8 11.5 14.3 EV/EBITDA (x) FY15E 8.8 5.0 9.6 FY16E 7.4 3.7 8.1 Div. Yield (%) FY15E 3.4 0.3 2.6 FY16E 3.4 0.4 3.1 P/BV (x) FY15E 3.5 1.2 4.6 FY16E 3.1 1.0 4.0 EPS: MOSL forecast v/s consensus (INR) MOSL Consensus Variation Forecast Forecast (%) FY15 7.5 8.3 -9.2 FY16 9.3 9.7 -4.0 Target price and recommendation Current Target Upside Reco. Price (INR) Price (INR) (%) 119 150 26 Buy Shareholding pattern (%) Mar-14 Dec-13 Mar-13 Promoter 62.6 61.6 61.6 DII 9.1 5.3 13.0 FII 14.0 7.3 12.6 Others 14.4 25.7 12.8 Notes: FII includes depository receipts Stock performance (1-year)
  • 6. 31 July 2014 6 Jagran Prakashan Financials and valuation
  • 7. 31 July 2014 7 Jagran Prakashan N O T E S
  • 8. 31 July 2014 8 Jagran Prakashan Disclosures This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt’s interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement JAGRAN PRAKASHAN LTD  Analyst ownership of the stock No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Anosh Koppikar Kadambari Balachandran Email:anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact(+65)68189232 Contact: (+65) 68189233 / 65249115 Office Address:21 (Suite 31),16 Collyer Quay,Singapore 04931 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com